|
2010 | 1. | Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T; CAPNETZ Study Group. 2010. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ. Thorax 65(3): 208-214
 PubMed |
| |
|
| | | | | |
2009 | 1. | Herr C, Kandler K, Beisswenger C, Hess C, Suttorp N, Welte T, Schröder
JM, Vogelmeier C and Bals R for the CAPNETZ Study Group. 2009. Suppression of pulmonary innate host
defense in smokers. Thorax 64(2): 144-149.
PubMed |
| 2. | Witzenrath M, Gutbier B, Schmeck B, Tenor H, Seybold J, Kuelzer R, Grentzmann G, Hatzelmann A, van Laak V, Tschernig T, Mitchell TJ, Schudt C, Rosseau S, Suttorp N and Schütte H. 2009. Phosphodiesterase 2 inhibition diminished acute lung injury in murine pneumococcal pneumonia. Crit Care Med 37: 584–590.
PubMed |
| 3. | Witzenrath M, Schmeck B, Doehn JM, Tschernig T, Zahlten J, Loeffler JM, Zemlin M, Müller H, Gutbier B, Schütte H, Hippenstiel S, Fischetti VA, Suttorp N and Rosseau S. 2009. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Crit Care Med 37: 642– 649.
PubMed |
| 4. | Welte T and Köhnlein T. 2009. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin Respir Crit Care Med 30[2], 127-35.
 PubMed |
| 5. | Tessmer A, Welte T, Martus P, Schnoor M, Marre R and Suttorp N. 2009. Impact of intravenous ß-lactam/macrolide versus ß-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. J Antimicrob
Chemother May;63(5):1025-33
PubMed |
| 6. | Krüger S, Ewig S, Kunde J, Hanschmann A, Marre R, Suttorp N, Welte T; CAPNETZ study group. 2009. C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia-influence of antibiotic pre-treatments: results from the German competence network CAPNETZ. J Antimicrob Chemother 64(1):159-62.
PubMed |
| 7. | von Baum H, Welte T, Marre R, Suttorp N, Lück C, Ewig S. 2009. Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). BMC Infect Dis 2009 May 13;9:62
PubMed |
| 8. | von Baum H, Welte T, Marre R, Suttorp N, Ewig S; for the CAPNETZ Study Group. 2009.
Community-acquired pneumonia through enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors. Eur Respir J. 2009 Aug 13. [Epub ahead of print]
PubMed |
| 9. | Krüger S, Ewig S, Papassotiriou J, Kunde J, Marre R, von Baum H, Suttorp N, Welte T; CAPNETZ Study Group. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ. Respir Res. 2009 Jul 12;10:65
PubMed |
| 10. | Schnoor M, Schoefer Y, Henrich G, Raspe H, Schaefer T. General and health-related life satisfaction of patients with community-acquired pneumonia. Psychol Health Med. 2009 May;14(3):331-42
PubMed |
|
2008 | 1. | Beisswenger C and Bals R. 2008. Interaction of allergic airway inflammation and innate immunity: hygiene and beyond. J Occup Med Toxicol 3 Suppl 1, S3.
PubMed |
| 2. | Borchardt J, Helbig JH and Lück PC. 2008. Occurrence and distribution of sequence types among Legionella pneumophila strains isolated from patients in Germany: common features and differences to other regions of the world. Eur J Clin Microbiol Infect Dis 27[1], 29-36.
PubMed |
| 3. | Cabanski M, Steinmüller M, Marsh LM, Surdziel E, Seeger W and Lohmeyer J. 2008. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages. Am J Respir Cell Mol Biol 38[1], 26-31.
PubMed |
| 4. | Galka F, Wai SN, Kusch H, Engelmann S, Hecker M, Schmeck B, Hippenstiel S, Uhlin BE and Steinert M. 2008. Proteomic characterisation of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles. Infect Immun 76[5], 1825-1836.
PubMed |
| 5. | Hocke AC, Hartmann IK, Eitel J, Optiz B, Scharf S, Suttorp N and Hippenstiel S. 2008. Subcellular expression pattern and role of IL-15 in pneumococci induced lung epithelial apoptosis. Histochem Cell Biol 130 [1], 165-176.
PubMed |
| 6. | Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K and the CAPNETZ study group. 2008. Outcome of community-acquired pneumonia: influence of age, residence status, and antimicrobial treatment. Eur Respir J 32[1], 139-146.
PubMed |
| 7. | Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T and CAPNETZ Study Group. 2008. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 31[2], 349-355.
PubMed |
| 8. | Schmeck B, Beermann W, N'Guessan PD, Hocke AC, Opitz B, Eitel J, Dinh QT, Witzenrath M, Krüll M, Suttorp N and Hippenstiel S. 2008. Simvastatin Reduces Chlamydophila pneumoniae-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells. Circ Res 25[102], 888-895.
PubMed |
| 9. | Schmeck
B, Lorenz J, N'Guessan PD, Opitz B, van Laak V, Zahlten J, Slevogt H, Witzenrath
M, Flieger A, Suttorp N, and Hippenstiel S. 2008. Histone acetylation and
flagellin are essential for Legionella pneumophila-induced cytokine expression.
J Immunol 181[2], 940-947.
PubMed |
| 10. | von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, Lück C and CAPNETZ Study Group. 2008. Community-acquired Legionella pneumonia. New insights from the German competence network for community acquired pneumonia. Clin Infect Dis 46[9], 1356-1364.
PubMed |
|
2007 | 1. | Dumke R, Schurwanz N, Lenz M, Schuppler M, Lück C and Jacobs E. 2007. Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach. J Clin Microbiol 45[8], 2726-2730.
PubMed |
| 2. | Hammerschmidt S, Agarwal V, Kunert A, Haelbich S, Skerka C and Zipfel PF. 2007. The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae an d mediates adhesion to host epithelial cells. J Immunol 178[9], 5848-5858.
PubMed |
| 3. | Hippenstiel S, Witzenrath M, Opitz B, Schütte H, Rosseau S and Suttorp N. 2007. Neues zur Pathophysiologie der Pneumonie [New aspects of the pathophysiology of pneumonia]. Internist (Berl) 48[5], 459-60, 462-4, 466-7.
PubMed |
| 4. | Hocke AC, Lampe MP, Witzenrath M, Mollenkopf H, Zerrahn J, Schmeck B, Kessler U, Krüll M, Hammerschmidt S, Hippenstiel S, Schütte H, Suttorp N and Rosseau S. 2007. Cell-specific interleukin-15 and interleukin-15 receptor subunit expression and regulation in pneumococcal pneumonia-comparison to chlamydial lung infection. Cytokine 38[2], 61-73.
PubMed |
| 5. | Kohlhammer Y, Raspe H, Marre R, Suttorp N, Welte T, Schäfer T and CAPNETZ study group. 2007. Antibiotic treatment of community acquired pneumonia varies widely across Germany. J Infect 54[5], 446-453.
PubMed |
| 6. | Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T and CAPNETZ Study Group. 2007. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German comptetence network CAPNETZ. Intensive Care Med 33[12], 2069-2078.
PubMed |
| 7. | Lück PC, Ecker C, Reischl U, Linde HJ and Stempka R. 2007. Culture-independent identification of the source of an infection by direct amplification and sequencing of Legionella pneumophila DNA from a clinical specimen. J Clin Microbiol 45[9], 3143-3144.
PubMed |
| 8. | N'Guessan PD, Etouem MO, Schmeck B, Hocke AC, Scharf S, Vardarova K, Opitz B, Flieger A, Suttorp N and Hippenstiel S. 2007. Legionella pneumophila-induced PK Calpha-, MAPK-, and NF-kappaB-dependent COX-2 expression in human lung epithelium. Am J Physiol Lung Cell Mol Physiol 292[1], L267-L277.
PubMed |
| 9. | Opitz B, Hippenstiel S, Eitel J and Suttorp N. 2007. Extra- and intracellular innate immune recognition in endothelial cells. Thromb Haemost 98[2], 319-326.
PubMed |
| 10. | Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N and Wolff T. 2007. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9[4], 930-938.
PubMed |
| 11. | Paul S, Krüger S, Richter K, Muche R, Marre R, Welte T, Billich C, Gonschior S, Schumann C, Boll D, Aschoff AJ and Suttorp N. 2007. Detektion pneumonischer Infiltrate bei ambulant erworbener Pneumonie: Übereinstimmung in der Befundung der Röntgen-Thoraxaufnahme [Interobserver agreement in the assessment of pulmonary infiltrates on chest radiography in community-acquired pneumonia]. Rofo 179[11], 1152-1158.
PubMed |
| 12. | Ratzow S, Gaia V, Helbig JH, Fry NK and Lück PC. 2007. Addition of neuA, the gene encoding N-acylneuraminate cytidylyl transferase, increases the discriminatory ability of the consensus sequence-based scheme for typing Legionella pneumophila serogroup 1 strains. J Clin Microbiol 45[6], 1965-1968.
PubMed |
| 13. | Rosseau S, Hocke A, Mollenkopf H, Schmeck B, Suttorp N, Kaufmann SH and Zerrahn J. 2007. Comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza A virus infection. Immunology 120[3], 380-391.
PubMed |
| 14. | Schmeck B, N'Guessan PD, Ollomang M, Lorenz J, Zahlten J, Opitz B, Flieger A, Suttorp N and Hippenstiel S. 2007. Legionella pneumophila-induced NF-kappaB- and MAPK-dependent cytokine release by lung epithelial cells. Eur Respir J 29[1], 25-33.
PubMed |
| 15. | Schnoor M, Hedicke J, Dalhoff K, Raspe H, Schäfer T and CAPNETZ Study Group. 2007. Approaches to estimate the population-based incidence of community acquired pneumonia. J Infect 55[3], 233-239.
PubMed |
| 16. | Schnoor M, Klante T, Beckmann M, Robra BP, Welte T, Raspe H, Schäfer T and CAPNETZ Study Group. 2007. Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect 135[8], 1389-1397.
PubMed |
| 17. | Schoefer Y, Schaberg T, Raspe H and Schäfer T. 2007. Determinants of influenza and pneumococcal vaccination in patients with chronic lung diseases. J Infect 55[4], 347-352.
PubMed |
| 18. | Slevogt H, Seybold J, Tiwari KN, Hocke AC, Jonatat C, Dietel S, Hippenstiel S, Singer BB, Bachmann S, Suttorp N and Opitz B. 2007. Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2- and partly NOD1-dependent inflammatory immune response. Cell Microbiol 9[3], 694-707.
PubMed |
| 19. | Suttorp N, Welte T and Marre R. 2007. Community-Acquired Pneumonia. Birkhäuser Advances in Infectious Diseases. Series Editors Schmidt A, Wolff MH and Kaufmann SHE.
Birkhäuser Verlag, Basel - Boston - Berlin. |
| 20. | von Wulffen W, Steinmueller M, Herold S, Marsh LM, Bulau P, Seeger W, Welte T, Lohmeyer J and Maus UA. 2007. Lung dendritic cells elicited by Fms-like tyrosine 3-kinase ligand amplify the lung inflammatory response to lipopolysaccharide. Am J Respir Crit Care Med 176[9], 892-901.
PubMed |
| 21. | Welte T. 2007. Therapie der ambulant erworbenen Pneumonie [Treatment of community acquired pneumonia]. Internist 48[5], 476-488.
PubMed |
| 22. | Witzenrath M, Gutbier B, Owen JS, Schmeck B, Mitchell TJ, Mayer K, Thomas MJ, Ishii S, Rosseau S, Suttorp N and Schütte H. 2007. Role of platelet-activating factor in pneumolysin-induced acute lung injury. Crit Care Med 35[7], 1756-1762.
PubMed |
2006 | 1. | Bauer T. 2006. CAPNETZ: Das Kompetenznetzwerk der ambulant erworbenen Pneumonie in Deutschland. [CAPNETZ: Competence network for community acquired pneumonia in Germany]. Pneumologie 60[2], 111-113.
PubMed |
| 2. | Bauer TT, Ewig S, Marre R, Suttorp N, Welte T and the CAPNETZ Study Group. 2006. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 260[1], 93-101.
PubMed |
| 3. | Beisswenger C, Kandler K, Hess C, Garn H, Felgentreff K, Wegmann M, Renz H, Vogelmeier C and Bals R. 2006. Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol 177[3], 1833-1837.
PubMed |
| 4. | Bergmann S and Hammerschmidt S. 2006. Versatility of pneumococcal surface proteins. Microbiology 152[Pt 2], 295-303.
PubMed |
| 5. | Dumke R, Lück PC, Noppen C, Schaefer C, von Baum H, Marre R and Jacobs E. 2006. Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J Clin Microbiol 44[7], 2567-2570.
PubMed |
| 6. | Felgentreff K, Beisswenger C, Griese M, Gulder T, Bringmann G and Bals R. 2006. The antimicrobial peptide cathelicidin interacts with airway mucus. Peptides 27[12], 3100-3106.
PubMed |
| 7. | Hamann L, Glaeser C, Hamprecht A, Gross M, Gomma A and Schumann RR. 2006. Toll-like receptor (TLR)-9 promotor polymophisms and atherosclerosis. Clin Chim Acta 364[1-2], 303-307.
PubMed |
| 8. | Hammerschmidt S. 2006. Adherence molecules of pathogenic pneumococci. Curr Opin Microbiol 9[1], 12-20.
PubMed |
| 9. | Hedicke J, Schnoor M, Schübel N, Gadji D, Dalhoff K, Raspe H and Schäfer T. 2006. Ergebnisvergleich: Aktives versus passives Meldesystem bei Fällen mit ambulant erworbener Pneumonie. Ergebnisse aus dem Kompetenznetzwerk CAPNETZ [Results of a comparison: acive versus passive reporting in cases of community acquired pneumonia. Results of the German Competence Network CAPNETZ]. Gesundheitswesen 68[10], 638-642.
PubMed |
| 10. | Hermans PW, Adrian PV, Albert C, Esteavo S, Hoogenboezem T, Luijendijk IH, Kamphausen T and Hammerschmidt S. 2006. The streptococcal lipoprotein rotamase A (SlrA) is a functional peptidyl-prolyl isomerase involved in pneumococcal colonization. J Biol Chem 281[2], 968-976.
PubMed |
| 11. | Herold S, von Wulffen W, Steinmueller M, Pleschka S, Kuziel WA, Mack M, Srivastava M, Seeger W, Maus UA and Lohmeyer J. 2006. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol 177[3], 1817-1824.
PubMed |
| 12. | Hippenstiel S, Opitz B, Schmeck B and Suttorp N. 2006. Lung epithelium as a sentinel and effector system in pneumonia - molecular mechanisms of pathogen recognition and signal transduction. Respir Res 7, 97.
PubMed |
| 13. | Koch M, Witzenrath M, Reuter C, Herma M, Schütte H, Suttorp N, Collins H and Kaufmann SH. 2006. Role of local pulmonary IFN-gamma expression in murine allergic airway inflammation. Am J Respir Cell Mol Biol 35[2], 211-219.
PubMed |
| 14. | Krüll M, Bockstaller P, Wuppermann FN, Klucken AC, Mühling J, Schmeck B, Seybold J, Walter C, Maass M, Rosseau S, Hegemann JH, Suttorp N and Hippenstiel S. 2006. Mechanisms of Chlamydophila pneumoniae-mediated GM-CSF release in human bronchial epithelial cells. Am J Respir Cell Mol Biol 34[3], 375-382.
PubMed |
| 15. | Kuhnke A, Welte T and Suttorp N. 2006. Pneumonie - erregerbasierte oder konstellationsbasierte Therapie? [Pneumonia - pathogen-based or constellation-based therapy?]. Internist (Berl) 47 Suppl 1, S14-S19.
PubMed |
| 16. | Lück PC and Steinert M. 2006. Pathogenese, Diagnostik und Therapie der Legionella-Infektion [Pathogenesis, diagnosis and therapy of Legionella infections]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 49[5], 439-449.
PubMed |
| 17. | Lück PC, Helbig JH, von Baum H and Marre R. 2006. Diagnostics and clinical disease treatment: Usefulness of microbiological diagnostic methods for detection of legionella infections. Legionella: State of the Art 30 years after its Recognition, 15-21. ASM Press, Washington D.C. |
| 18. | Maus UA, Janzen S, Wall G, Srivastava M, Blackwell TS, Christman JW, Seeger W, Welte T and Lohmeyer J. 2006. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol 35[2], 227-235.
PubMed |
| 19. | N'Guessan PD, Hippenstiel S, Etouem MO, Zahlten J, Beermann W, Lindner D, Opitz B, Witzenrath M, Rosseau S, Suttorp N and Schmeck B. 2006. Streptococcus pneumoniae induced p38 MAPK- and NF-kappaB-dependent COX-2 expression in human lung epithelium. Am J Physiol Lung Cell Mol Physiol 290[6], L1131-L1138.
PubMed |
| 20. | Opitz B, Püschel A, Beermann W, Hocke AC, Förster S, Schmeck B, van Laak V, Chakraborty T, Suttorp N and Hippenstiel S. 2006. Listeria monocytogenes activated p38 MAPK and induced IL-8 secretion in a nucleotide-binding oligomerization domain 1-dependent manner in endothelial cells. J Immunol 176[1], 484-490.
PubMed |
| 21. | Opitz B, Vinzing M, van Laak V, Schmeck B, Heine G, Günther S, Preissner R, Slevogt H, N'Guessan PD, Eitel J, Goldmann T, Flieger A, Suttorp N and Hippenstiel S. 2006. Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J Biol Chem 281[47], 36173-36179.
PubMed |
| 22. | Schmeck
B, Huber S, Moog K, Zahlten J, Hocke AC, Opitz B, Hammerschmidt S, Mitchell TJ,
Kracht M, Rosseau S, Suttorp N, and Hippenstiel S. 2006. Pneumococci induced
TLR- and Rac1-dependent NF-kappaB-recruitment to the IL-8 promoter in lung
epithelial cells. Am J Physiol Lung Cell Mol Physiol 290[4], L730-L737.
PubMed |
| 23. | Schmeck B, Moog K, Zahlten J, van Laak V, N'Guessan
PD, Opitz B, Rosseau S, Suttorp N, and Hippenstiel S. 2006. Streptococcus
pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by
lung epithelial BEAS-2B cells. Respir Res 7, 98.
PubMed |
| 24. | Schmeck B, Beermann W, van Laak V, Opitz B, Hocke AC,
Meixenberger K, Eitel J, Chakraborty T, Schmidt G, Barth H, Suttorp N, and
Hippenstiel S. 2006. Listeria monocytogenes induced Rac1-dependent signal
transduction in endothelial cells. Biochem Pharmacol 72[11], 1367-1374.
PubMed |
| 25. | Shi C, Forsbach-Birk V, Marre R, and McNealy TL.
2006. The Legionella pneumophila global regulatory protein LetA affects DotA
and Mip. Int J Med Microbiol 296[1], 15-24.
PubMed. |
| 26. | Steinmüller M, Srivastava M, Kuziel WA, Christman
JW, Seeger W, Welte T, Lohmeyer J, and Maus UA. 2006. Endotoxin induced
peritonitis elicits monocyte immigration into the lung: implications on
alveolar space inflammatory responsiveness. Respir Res 7, 30.
PubMed |
| 27. | Wellinghausen N, Straube E, Freidank H, von Baum H,
Marre R, and Essig A. 2006. Low prevalence of Chlamydia pneumoniae in adults
with community-acquired pneumonia. Int J Med Microbiol 296[7], 485-491.
PubMed |
| 28. | Welte T, Marre R, Suttorp N and Kompetenznetzwerk "Ambulant erworbene Pneumonie" (CAPNETZ). 2006. Was gibt es
Neues in der Behandlung der ambulant erworbenen Pneumonie ? [What is new in the
treatment of community-acquired pneumonia?]. Med Klin (Munich) 101[4],
313-320.
PubMed |
| 29. | Witzenrath M, Ahrens B, Kube SM, Braun A, Hoymann
HG, Hocke AC, Rosseau S, Suttorp N, Hamelmann E, and Schütte H. 2006. Detection
of allergen-induced airway hyperresponsiveness in isolated mouse lungs. Am J
Physiol Lung Cell Mol Physiol 291[3], L466-L472.
PubMed |
| 30. | Witzenrath M, Gutbier B, Hocke AC, Schmeck B,
Hippenstiel S, Berger K, Mitchell TJ, de los Toyos JR, Rosseau S, Suttorp N, and
Schütte H. 2006. Role of pneumolysin for the development of acute lung injury
in pneumococcal pneumonia. Crit Care Med 34[7], 1947-1954.
PubMed |
| 31. | Witzenrath M, Ahrens B, Kube SM, Hocke AC, Rosseau
S, Hamelmann E, Suttorp N, and Schütte H. 2006. Allergic lung inflammation
induces pulmonary vascular hyperresponsiveness. Eur Respir J 28[2],
370-377.
PubMed |
2005 | 1. | Bergmann S, Rohde M, Preissner KT, and
Hammerschmidt S. 2005. The nine residue plasminogen-binding motif of the
pneumococcal enolase is the major cofactor of plasmin-mediated degradation of
extracellular matrix, dissolution of fibrin and transmigration. Thromb
Haemost 94[2], 304-311.
PubMed |
| 2. | Hamann L, Alexander C, Stamme C, Zähringer U, and
Schumann RR. 2005. Acute-phase concentrations of lipopolysaccharide
(LPS)-binding protein inhibit innate immune cell activation by different LPS
chemotypes via different mechanisms. Infect Immun 73[1], 193-200.
PubMed |
| 3. | Hammerschmidt S, Wolff S, Hocke A, Rosseau S,
Müller E, and Rohde M. 2005. Illustration of pneumococcal polysaccharide
capsule during adherence and invasion of epithelial cells. Infect Immun 73[8],
4653-4667.
PubMed |
| 4. | Hippenstiel S. 2005. Interaktion pulmonaler
Epithelzellen mit Streptococcus pneumoniae [Pneumococci -- epithelial
interaction]. Pneumologie 59[12], 895-896.
PubMed |
| 5. | Kohlhammer Y, Schwartz M, Raspe H, and Schäfer T.
2005. Risikofaktoren für die ambulant erworbene Pneumonie (Community Acquired
Pneumonia). Eine systematische Übersichtsarbeit [Risk factors for community acquired
pneumonia (CAP). A systematic review]. Dtsch Med Wochenschr 130[8],
381-386.
PubMed |
| 6. | Krüll M, Maass M, Suttorp N, and Rupp J. 2005.
Chlamydophila pneumoniae - Mechanisms of target cell infection and activation. Thrombosis
and Haemostasis 94[2], 319-326.
PubMed |
| 7. | Maus UA, Wellmann S, Hampl C, Kuziel WA, Srivastava
M, Mack M, Everhart MB, Blackwell TS, Christman JW, Schlöndorff D, Bohle RM,
Seeger W, and Lohmeyer J. 2005. CCR2-positive monocytes recruited to inflamed
lungs downregulate local CCL2 chemokine levels. Am J Physiol Lung Cell Mol
Physiol 288[2], L350-L358.
PubMed |
| 8. | McNealy TL, Forsbach-Birk V, Shi C, and Marre R. 2005.
The Hfq homolog in Legionella pneumophila demonstrates regulation by LetA and
RpoS and interacts with the global regulator CsrA. J Bacteriol 187[4],
1527-1532.
PubMed |
| 9. | N'Guessan PD, Schmeck B, Ayim A, Hocke AC, Brell B,
Hammerschmidt S, Rosseau S, Suttorp N, and Hippenstiel S. 2005. Streptococcus
pneumoniae R6x induced p38 MAPK and JNK-mediated caspase-dependent apoptosis in
human endothelial cells. Thromb Haemost 94[2], 295-303.
PubMed |
| 10. | Opitz B, Förster S, Hocke AC, Maass M, Schmeck B,
Hippenstiel S, Suttorp N, and Krüll M. 2005. Nod1-mediated endothelial cell
activation by Chlamydophila pneumoniae. Circ Res 96[3], 319-326.
PubMed |
| 11. | Pletz
MWR. 2005. Ambulant erworbene Pneumonie. Der Pneumologe 2[1], 17-27.
|
| 12. | Reinert RR, Haupts S, van der Linden M, Heeg C, Cil MY,
Al-Lahham A, and Fedson DS. 2005. Invasive pneumococcal disease in adults in
North-Rhine Westphalia, Germany, 2001-2003. Clin Microbiol Infect 11[12],
985-991.
PubMed |
| 13. | Reinert RR, Ringelstein A, van der Linden M, Cil MY, Al-Lahham A, and Schmitz FJ. 2005. Molecular epidemiology of macrolide-resistant
Streptococcus pneumoniae isolates in Europe. J Clin Microbiol 43[3],
1294-1300.
PubMed |
| 14. | Rosseau
S. 2005. Pneumokokkenpneumonie im Mausmodell [Pneumococcal pneumonia in a mouse
model]. Pneumologie 59[6], 419-420.
PubMed |
| 15. | Rosseau S, Wiechmann K, Moderer S, Selhorst J,
Mayer K, Krüll M, Hocke A, Slevogt H, Seeger W, Suttorp N, Seybold J, and
Lohmeyer J. 2005. Moraxella catarrhalis--infected alveolar epithelium induced
monocyte recruitment and oxidative burst. Am J Respir Cell Mol Biol 32[2],
157-166.
PubMed |
| 16. | Schmeck B, Beermann W, van Laak V, Zahlten J, Opitz
B, Witzenrath M, Hocke AC, Chakraborty T, Kracht M, Rosseau S, Suttorp N, and
Hippenstiel S. 2005. Intracellular bacteria differentially regulated
endothelial cytokine release by MAPK-dependent histone modification. J
Immunol 175[5], 2843-2850.
PubMed |
| 17. | Schröder NW, Diterich I, Zinke A, Eckert J, Draing
C, von Baehr V, Hassler D, Priem S, Hahn K, Michelsen KS, Hartung T, Burmester GR,
Göbel UB, Hermann C, and Schumann RR. 2005. Heterozygous Arg753Gln polymorphism
of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects
from late stage Lyme disease. J Immunol 175[4], 2534-2540.
PubMed |
| 18. | Schröder NW, Meister D, Wolff V, Christan C, Kaner
D, Haban V, Purucker P, Hermann C, Moter A, Göbel UB, and Schumann RR. 2005. Chronic
periodontal disease is associated with single-nucleotide polymorphisms of the
human TLR-4 gene. Genes Immun 6[5], 448-451.
PubMed |
| 19. | Seybold J, Thomas D, Witzenrath M, Boral S, Hocke
AC, Bürger A, Hatzelmann A, Tenor H, Schudt C, Krüll M, Schütte H, Hippenstiel
S, and Suttorp N. 2005. Tumor necrosis factor-alpha-dependent expression of
phosphodiesterase 2: role in endothelial hyperpermeability. Blood 105[9],
3569-3576.
PubMed |
| 20. | Srivastava M, Jung S, Wilhelm J, Fink L, Bühling F,
Welte T, Bohle RM, Seeger W, Lohmeyer J, and Maus UA. 2005. The inflammatory
versus constitutive trafficking of mononuclear phagocytes into the alveolar
space of mice is associated with drastic changes in their gene expression
profiles. J Immunol 175[3], 1884-1893.
PubMed |
| 21. | Welte T, Marre R, and Suttorp N. 2005. New
therapeutic strategies for community acquired pneumonia. Internist 46[12],
1354-1359.
PubMed |
2004 | 1. | Bergmann S, Rohde M, and Hammerschmidt S. 2004.
Glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pneumoniae is a
surface-displayed plasminogen-binding protein. Infect Immun 72[4],
2416-2419.
PubMed |
| 2. | Elm C, Braathen R, Bergmann S, Frank R, Vaerman JP,
Kaetzel CS, Chhatwal GS, Johansen FE, and Hammerschmidt S. 2004. Ectodomains 3
and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of
Streptococcus pneumoniae into the epithelium. J Biol Chem 279[8],
6296-6304.
PubMed |
| 3. | Forsbach-Birk V, McNealy T, Shi C, Lynch D, and
Marre R. 2004. Reduced expression of the global regulator protein CsrA in
Legionella pneumophila affects virulence-associated regulators and growth in
Acanthamoeba castellanii. Int J Med Microbiol 294[1], 15-25.
PubMed |
| 4. | Hallatschek W, Fiedler G, Kirschning CJ, Creutzburg
F, Lamping N, Nüssler A, and Schumann RR. 2004. Inhibition of hepatic
transcriptional induction of lipopolysaccharide-binding protein by
transforming-growth-factor beta 1. Eur J Immunol 34[5], 1441-1450.
PubMed |
| 5. | Hamann L, Hamprecht A, Gomma A, and Schumann RR.
2004. Rapid and inexpensive real-time PCR for genotyping functional
polymorphisms within the Toll-like receptor -2, -4, and -9 genes. J Immunol
Methods 285[2], 281-291.
PubMed |
| 6. | Hamann L, Kumpf O, Müller M, Visintin A, Eckert J,
Schlag PM, and Schumann RR. 2004. A coding mutation within the first exon of
the human MD-2 gene results in decreased lipopolysaccharide-induced signaling. Genes
Immun 5[4], 283-288.
PubMed |
| 7. | Hermann C, Gueinzius K, Oehme A, Von Aulock S,
Straube E, and Hartung T. 2004. Comparison of quantitative and semiquantitative
enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila
pneumoniae to a microimmunofluorescence test for use with patients with
respiratory tract infections. J Clin Microbiol 42[6], 2476-2479.
PubMed |
| 8. | Igel L, Helbig JH, and Lück PC. 2004. Isolation and
characterization of a nonfluorescent strain of Legionella parisiensis. J
Clin Microbiol 42[6], 2877-2878.
PubMed |
| 9. | Krüll M, Kramp J, Petrov T, Klucken AC, Hocke AC,
Walter C, Schmeck B, Seybold J, Maass M, Ludwig S, Kuipers JG, Suttorp N, and
Hippenstiel S. 2004. Differences in cell activation by Chlamydophila pneumoniae
and Chlamydia trachomatis infection in human endothelial cells. Infect Immun
72[11], 6615-6621.
PubMed |
| 10. | Lück PC, Igel L, Helbig JH, Kuhlisch E, and
Jatzwauk L. 2004. Comparison of commercially available media for the recovery
of Legionella species. Int J Hyg Environ Health 207[6], 589-593.
PubMed |
| 11. | Marre R and von Baum H. 2004. Welche Erreger machen
krank bei der ambulant erworbenen Pneumonie? [Which pathogens occur in
community acquired pneumonia? First results of CAPNETZ]. Med Welt 55[10],
319-321.
Die Medizinische Welt |
| 12. | Maus UA, Srivastava M, Paton JC, Mack M, Everhart
MB, Blackwell TS, Christman JW, Schlöndorff D, Seeger W, and Lohmeyer J. 2004.
Pneumolysin-induced lung injury is independent of leukocyte trafficking into
the alveolar space. J Immunol 173[2], 1307-1312.
PubMed |
| 13. | Opitz B, Püschel A, Schmeck B, Hocke AC, Rosseau S,
Hammerschmidt S, Schumann RR, Suttorp N, and Hippenstiel S. 2004.
Nucleotide-binding oligomerization domain proteins are innate immune receptors
for internalized Streptococcus pneumoniae. J Biol Chem 279[35],
36426-36432.
PubMed |
| 14. | Reinert RR, Franken C, van der Linden M, Lütticken R, Cil
M and Al-Lahham A. 2004. Molecular characterisation of macrolide resistance
mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in
Germany, 2002-2003. Int J Antimicrob Agents 24[1], 43-47.
PubMed |
| 15. | Reinert RR. 2004. Bedeutung von Pneumokokken bei
der ambulant erworbenen Pneumonie (CAP) [Importance of Streptococcus in
community acquired pneumonia(CAP)]. Med Welt 55[10], 322-326.
Die Medizinische Welt |
| 16. | Rosseau S, Schmeck B, and Suttorp N. 2004.
Pathogenese der Pneumonie [Pathogenesis of pneumonia – mechanisms of lung
innate immunity]. Med Welt 55[10], 337-341.
Die Medizinische Welt |
| 17. | Rödel J, Prochnau D, Prager K, Baumert J, Schmidt
KH, and Straube E. 2004. Chlamydia pneumoniae decreases smooth muscle cell
proliferation through induction of prostaglandin E2 synthesis. Infect Immun 72[8], 4900-4904.
PubMed |
| 18. | Rupp J, Droemann D, Goldmann T, Zabel P, Solbach W,
Vollmer E, Branscheid D, Dalhoff K, and Maass M. 2004. Alveolar epithelial
cells type II are major target cells for C. pneumoniae in chronic but not in
acute respiratory infection. FEMS Immunol Med Microbiol 41[3], 197-203.
PubMed |
| 19. | Schmeck B, Zahlten J, Moog K, van Laak, V, Huber S,
Hocke AC, Opitz B, Hoffmann E, Kracht M, Zerrahn J, Hammerschmidt S, Rosseau S,
Suttorp N, and Hippenstiel S. 2004. Streptococcus pneumoniae-induced p38
MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor. J Biol
Chem 279[51], 53241-53247.
PubMed |
| 20. | Schmeck B, Gross R, N'Guessan PD, Hocke AC,
Hammerschmidt S, Mitchell TJ, Rosseau S, Suttorp N, and Hippenstiel S. 2004.
Streptococcus pneumoniae-induced caspase 6-dependent apoptosis in lung
epithelium. Infect Immun 72[9], 4940-4947.
PubMed |
| 21. | Schmitz-Esser S, Linka N, Collingro A, Beier CL,
Neuhaus HE, Wagner M, and Horn M. 2004. ATP/ADP translocases: a common feature
of obligate intracellular amoebal symbionts related to Chlamydiae and
Rickettsiae. J Bacteriol 186[3], 683-691.
PubMed |
| 22. | Schröder NW, Heine H, Alexander C, Manukyan M,
Eckert J, Hamann L, Göbel UB, and Schumann RR. 2004. Lipopolysaccharide binding
protein binds to triacylated and diacylated lipopeptides and mediates innate
immune responses. J Immunol 173[4], 2683-2691.
PubMed |
| 23. | Schweiger B. 2004. Viren als Ursache der ambulant
erworbenen Pneumonie [Viruses causing community acquired pneumonia]. Med
Welt 55[10], 327-331.
Die Medizinische Welt |
| 24. | Walter C, Zahlten J, Schmeck B, Schaudinn C,
Hippenstiel S, Frisch E, Hocke AC, Pischon N, Kuramitsu HK, Bernimoulin JP,
Suttorp N, and Krüll M. 2004. Porphyromonas gingivalis strain-dependent
activation of human endothelial cells. Infect Immun 72[10], 5910-5918.
PubMed |
| 25. | Weber M. 2004. Struktur der Informationstechnologie
in einem Kompetenznetzwerk [Structure of the information technology in a
competence network]. Med Welt 55[10], 315-318.
Die Medizinische Welt |
| 26. | Welte T, Suttorp N, and Marre R. 2004. CAPNETZ -
Community-acquired pneumonia competence network. Infection 32[4],
234-238.
PubMed |
| 27. | Welte T, Marre R, and Suttorp N. 2004. Das
Kompetenznetzwerk Ambulant erworbene Pneumonie (CAPNETZ). Ein erster
Zwischenbericht. [Competence network "community acquired pneumonia"
(CAPNETZ). A first interim report]. Internist (Berl) 45[4], 393-401.
PubMed |
| 28. | Welte T. 2004. Therapie der ambulant erworbenen
Pneumonie [Treatment of community acquired pneumonia]. Med Welt 55[10],
332-336.
Die Medizinische Welt |
2003 | 1. | Bergmann S, Wild D, Diekmann O, Frank R, Bracht D,
Chhatwal GS, and Hammerschmidt S. 2003. Identification of a novel
plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus
pneumoniae. Mol Microbiol 49[2], 411-423.
PubMed |
| 2. | Reinert RR, Muckel S, Al Lahham A, Spratt BG,
Brueggemann AB, Hakenbeck R, and Lutticken R. 2003. Characterization of German
penicillin non-susceptible serotype 23F pneumococci using multilocus sequence
typing. J Med Microbiol 52[Pt 11], 981-987.
PubMed |
| 3. | Reischl U, Lehn N, Simnacher U, Marre R, and Essig
A. 2003. Rapid and standardized detection of Chlamydia pneumoniae using
LightCycler real-time fluorescence PCR. Eur J Clin Microbiol Infect Dis 22[1],
54-57.
PubMed |
| 4. | Schröder NW, Morath S, Alexander C, Hamann L,
Hartung T, Zahringer U, Göbel UB, Weber JR, and Schumann RR. 2003. Lipoteichoic
acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates
immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein
(LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278[18],
15587-15594.
PubMed |
| 5. | Schröder NW, Hermann C, Hamann L, Göbel UB, Hartung
T, and Schumann RR. 2003. High frequency of polymorphism Arg753Gln of the
Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med
81[6], 368-372.
PubMed |
| 6. | Tuschy P, Welte T, Marre R, Suttorp N, Lorenz J,
Fätkenheuer G, and Ewig S. 2003. Das schwere akute Atemwegssyndrom
[SARS--Severe Acute Respiratory syndrome]. Pneumologie 57[5], 256-258.
PubMed |
| 7. | Weber JR, Freyer D, Alexander C, Schröder NW, Reiss
A, Küster C, Pfeil D, Tuomanen EI, and Schumann RR. 2003. Recognition of pneumococcal
peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 19[2],
269-279.
PubMed |
| 8. | Welte T, Marre R, and Suttorp N. 2003. CAPNetz -
Kompetenznetzwerk ambulant erworbene Pneumonie: Strukturen und Ziele
[CAPNet--network of competence for community acquired pneumonia: structures and
aims]. Pneumologie 57[1], 34-41.
PubMed |
2002 | 1. | Poppert S, Essig A, Marre R, Wagner M, and Horn M.
2002. Detection and differentiation of chlamydiae by fluorescence in situ
hybridization. Appl Environ Microbiol 68[8], 4081-4089.
PubMed |
2001 | 1. | Horn M and Wagner M. 2001. Evidence for additional
genus-level diversity of Chlamydiales in the environment. FEMS Microbiol
Lett 204[1], 71-74.
PubMed |
|
|
|
